H.R. 796 explained  ·  119th Congress  ·  Pending in Congress

Second Chance for Moms Act

Create a free account or sign in to follow H.R. 796 and get alerts. Policy area: Health Create a free account or sign in to follow the Health policy area and get alerts. ▲ 629 days since action Sponsor: Mary E. Miller, IL-15, R → Congress.gov

Cosponsors: 13 (0 D, 13 R) · per Congress.gov, 2026-10-12

Introduced: 2025-01-28

Latest action (2025-01-28): Referred to the House Committee on Energy and Commerce.

What H.R. 796 does, in plain terms

Second Chance for Moms Act of 2025 This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

Official summary by the Congressional Research Service, via Congress.gov.

Constitution Index

“VFA Constitution grade”

Not graded yet

H.R. 796 has not been graded yet. New measures with an official summary are graded daily under the published rubric.

What should pass

“VFA SI Solution”

No solution yet

A sourced SI draft appears here once it passes automated checks (Constitution citation, source verification, independent SI critic). How publication works.

Share card

1200×675 PNG for X, Threads, LinkedIn and messages. Free to share with a link back to this page.

For journalists and bloggers

“Embed this grade”

Free to use with the link back. The badge and card update when the grade changes. Embed terms →

VFA Constitution grade for H.R. 796

← Back to the Republic